SpringWorks Therapeutics to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
SpringWorks Therapeutics(SWTX) GlobeNewswire News Room·2024-11-05 20:00
STAMFORD, Conn., Nov. 05, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that management will participate in a fireside chat at Guggenheim’s Inaugural Healthcare Innovation Conference, taking place in Boston, Massachusetts on Wednesday, November 13, 2024 at 1:00 p.m. ET. To access the live webcast, please visit the Events & Presentations page within the Investors & Media section ...